Literature DB >> 18765110

The invasive T1 bladder tumor: contemporary issues and rationale for radical cystectomy.

John P Stein1, David F Penson.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18765110     DOI： 10.1007/s11934-008-0031-2

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN： 1527-2737            Impact factor:   3.092


× No keyword cloud information.
  22 in total

1.  Indications for early cystectomy.

Authors:  John P Stein
Journal:  Urology       Date:  2003-10       Impact factor: 2.649

2.  Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.

Authors:  J Huguet; M Crego; S Sabaté; J Salvador; J Palou; H Villavicencio
Journal:  Eur Urol       Date:  2005-04-07       Impact factor: 20.096

3.  A retrospective analysis of 153 patients treated with or without intravesical bacillus Calmette-Guerin for primary stage T1 grade 3 bladder cancer: recurrence, progression and survival.

Authors:  Osama Shahin; George N Thalmann; Cyrill Rentsch; L Mazzucchelli; U E Studer
Journal:  J Urol       Date:  2003-01       Impact factor: 7.450

4.  Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.

Authors:  D L Lamm; B A Blumenstein; J D Crissman; J E Montie; J E Gottesman; B A Lowe; M F Sarosdy; R D Bohl; H B Grossman; T M Beck; J T Leimert; E D Crawford
Journal:  J Urol       Date:  2000-04       Impact factor: 7.450

Review 5.  Surgical factors in the treatment of superficial and invasive bladder cancer.

Authors:  Harry W Herr
Journal:  Urol Clin North Am       Date:  2005-05       Impact factor: 2.241

6.  Lymph node metastases in non-muscle invasive bladder cancer are correlated with the number of transurethral resections and tumour upstaging at radical cystectomy.

Authors:  Christoph Wiesner; Jesco Pfitzenmaier; Andreas Faldum; Rolf Gillitzer; Sebastian W Melchior; Joachim W Thüroff
Journal:  BJU Int       Date:  2005-02       Impact factor: 5.588

Review 7.  High-risk superficial bladder cancer: intravesical therapy for T1 G3 transitional cell carcinoma of the urinary bladder.

Authors:  H T Pham; M S Soloway
Journal:  Semin Urol Oncol       Date:  1997-08

8.  Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy?

Authors:  Harry W Herr; S Machele Donat; Guido Dalbagni
Journal:  J Urol       Date:  2007-01       Impact factor: 7.450

9.  Intravesical bacillus Calmette-Guerin therapy for stage T1 grade 3 transitional cell carcinoma of the bladder: recurrence, progression and survival in a study of 57 patients.

Authors:  Michael Peyromaure; Florent Guerin; Delphine Amsellem-Ouazana; Djillali Saighi; Bernard Debre; Marc Zerbib
Journal:  J Urol       Date:  2003-06       Impact factor: 7.450

10.  Cancer statistics, 2006.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Taylor Murray; Jiaquan Xu; Carol Smigal; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2006 Mar-Apr       Impact factor: 508.702
View more
  1 in total

Review 1.  Emerging intravesical therapies for management of nonmuscle invasive bladder cancer.

Authors:  Jeffrey J Tomaszewski; Marc C Smaldone
Journal:  Open Access J Urol       Date:  2010-05-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.